Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=37311740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20060559(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Publication of PE20060559A1publicationCriticalpatent/PE20060559A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
REFERIDA A UN COMPUESTO DE CARBAMATO DE FORMULA I O II, DONDE EL FENILO ES SUSTITUIDO EN X CON UNO A CINCO ATOMOS DE FLUOR, CLORO, BROMO Y YODO; R1, R2, R3, R4, R5 Y R6 SON H, ALQUILO C1-C4, ENTRE OTROS. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE TRASTORNOS RELACIONADOS CON LA DEPENDENCIA DE SUSTANCIAS, TRASTORNOS ASOCIADOS A LA ADICCION Y SINTOMAS DE LOS MISMOS.REFERRING TO A CARBAMATE COMPOUND OF FORMULA I OR II, WHERE THE PHENYL IS SUBSTITUTED IN X WITH ONE TO FIVE ATOMS OF FLUORINE, CHLORINE, BROMINE AND IODINE; R1, R2, R3, R4, R5 AND R6 ARE H, C1-C4 ALKYL, AMONG OTHERS. SUCH COMPOUNDS ARE USEFUL IN THE TREATMENT OF SUBSTANCE DEPENDENCE RELATED DISORDERS, ADDICTION-ASSOCIATED DISORDERS AND SYMPTOMS OF THE SAME
PE2005000743A2004-06-302005-06-27
CARBAMATE-DERIVED COMPOUNDS FOR THE TREATMENT OF SUBSTANCE-RELATED DISORDERS
PE20060559A1
(en)
COMPOUNDS OF [N-BENZOIL] -PENYL SULFONAMIDE AND N- [PHENYL SULFONIL] -BENZAMIDINE; METHODS TO TREAT NEOPLASIAS IN SUSCEPTIBLE MAMMALS, USING SUCH COMPOUNDS AND COMPOSITIONS FORMED BY THESE COMPOSED METHODS
BENZOTIAZOLES HETEROARIL REPLACED, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THERAPEUTIC USES, BETWEEN THEM, IN THE TREATMENT AND / OR PREVENTION OF ALZHEIMER'S DISEASE.